Thermal stability, pH dependence and inhibition of four murine kynurenine aminotransferases

BMC Biochemistry

Volumn 11, Issue 1, 2010, Pages

  Han, Qian ^a   Cai, Tao ^b   Tagle, Danilo A ^c   Li, Jianyong ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINOADIPATE AMINOTRANSFERASE; AMINO ACID; AMINOADIPIC ACID; ASPARAGINE; ASPARTATE AMINOTRANSFERASE ISOENZYME 2; ASPARTIC ACID; CYSTEINE; CYSTEINE CONJUGATE BETA LYASE; CYSTEINE CONJUGATE BETA LYASE 1; CYSTEINE CONJUGATE BETA LYASE 2; GLUTAMINE; GLUTAMINE PHENYLPYRUVATE AMINOTRANSFERASE; GLYOXYLIC ACID; HISTIDINE; KYNURENINE; LEUCINE; METHIONINE; OXOACID; PHENYLALANINE; TRYPTOPHAN; UNCLASSIFIED DRUG; AMINOTRANSFERASE; ISOPROTEIN; KYNURENINE OXOGLUTARATE TRANSAMINASE; KYNURENINE-OXOGLUTARATE TRANSAMINASE; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME SPECIFICITY; HALF LIFE TIME; HEAT TREATMENT; MALE; MELTING POINT; MOUSE; NONHUMAN; PH; PKA; TEMPERATURE; THERMOSTABILITY; ANIMAL; BRAIN; C57BL MOUSE; DRUG ANTAGONISM; ENZYMOLOGY; METABOLISM; PROTEIN DENATURATION; PROTEIN STABILITY;

MURINAE;

AMINO ACIDS; ANIMALS; ASPARTIC ACID; BRAIN; HALF-LIFE; HYDROGEN-ION CONCENTRATION; MALE; METHIONINE; MICE; MICE, INBRED C57BL; PROTEIN DENATURATION; PROTEIN ISOFORMS; PROTEIN STABILITY; RECOMBINANT PROTEINS; SUBSTRATE SPECIFICITY; TEMPERATURE; TRANSAMINASES; TRYPTOPHAN;

EID: 77952307038     PISSN: None     EISSN: 14712091     Source Type: Journal    
DOI: 10.1186/1471-2091-11-19     Document Type: Article

References (48)

1. The glycine site on the NMDA receptor: structure-activity relationships and therapeutic potential. Leeson PD, Iversen LL, J Med Chem 1994 37 24 4053 4067 10.1021/jm00050a001 7990104
2. An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid. Perkins MN, Stone TW, Brain Res 1982 247 1 184 187 10.1016/0006-8993(82)91048-4 6215086
3. Actions of excitatory amino acids and kynurenic acid in the primate hippocampus: a preliminary study. Stone TW, Perkins MN, Neurosci Lett 1984 52 3 335 340 10.1016/0304-3940(84)90184-8 6240611
4. Kynurenic acid antagonises responses to NMDA via an action at the strychnine-insensitive glycine receptor. Birch PJ, Grossman CJ, Hayes AG, Eur J Pharmacol 1988 154 1 85 87 10.1016/0014-2999(88)90367-6 2846328
5. Unconventional ligands and modulators of nicotinic receptors. Pereira EF, Hilmas C, Santos MD, Alkondon M, Maelicke A, Albuquerque EX, J Neurobiol 2002 53 4 479 500 10.1002/neu.10146 12436414
6. The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. Hilmas C, Pereira EF, Alkondon M, Rassoulpour A, Schwarcz R, Albuquerque EX, J Neurosci 2001 21 19 7463 7473 11567036
7. Targeted deletion of the kynurenine aminotransferase ii gene reveals a critical role of endogenous kynurenic acid in the regulation of synaptic transmission via alpha7 nicotinic receptors in the hippocampus. Alkondon M, Pereira EF, Yu P, Arruda EZ, Almeida LE, Guidetti P, Fawcett WP, Sapko MT, Randall WR, Schwarcz R, et al. J Neurosci 2004 24 19 4635 4648 10.1523/JNEUROSCI.5631-03.2004 15140935
8. Kynurenic acid blocks nicotinic synaptic transmission to hippocampal interneurons in young rats. Stone TW, Eur J Neurosci 2007 25 9 2656 2665 10.1111/j.1460-9568.2007.05540.x 17459105
9. Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35. Wang J, Simonavicius N, Wu X, Swaminath G, Reagan J, Tian H, Ling L, J Biol Chem 2006 281 31 22021 22028 10.1074/jbc.M603503200 16754668
10. Structure, expression, and function of kynurenine aminotransferases in human and rodent brains. Han Q, Cai T, Tagle DA, Li J, Cell Mol Life Sci 2010 67 3 353 368 10.1007/s00018-009-0166-4 19826765
11. Role of the medulla oblongata in hypertension. Colombari E, Sato MA, Cravo SL, Bergamaschi CT, Campos RR Jr, Lopes OU, Hypertension 2001 38 3 Pt 2 549 554 11566929
12. Excitatory amino acids in the rostral ventrolateral medulla support blood pressure in spontaneously hypertensive rats. Ito S, Komatsu K, Tsukamoto K, Sved AF, Hypertension 2000 35 1 Pt 2 413 417 10642334
13. A missense mutation in kynurenine aminotransferase-1 in spontaneously hypertensive rats. Kwok JB, Kapoor R, Gotoda T, Iwamoto Y, Iizuka Y, Yamada N, Isaacs KE, Kushwaha VV, Church WB, Schofield PR, et al. J Biol Chem 2002 277 39 35779 35782 10.1074/jbc.C200303200 12145272
14. Two kynurenine aminotransferases in human brain. Okuno E, Nakamura M, Schwarcz R, Brain Res 1991 542 2 307 312 10.1016/0006-8993(91)91583-M 2029638
15. Characterization of rat brain kynurenine aminotransferases I and II. Guidetti P, Okuno E, Schwarcz R, J Neurosci Res 1997 50 3 457 465 10.1002/(SICI)1097-4547(19971101)50:3<457::AID-JNR12>3.0.CO;2-3 9364331
16. Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities. Schwarcz R, Pellicciari R, J Pharmacol Exp Ther 2002 303 1 1 10 10.1124/jpet.102.034439 12235226
17. pH dependence, substrate specificity and inhibition of human kynurenine aminotransferase I. Han Q, Li J, Li J, Eur J Biochem 2004 271 4804 4814 10.1111/j.1432-1033.2004.04446.x 15606768
18. Characterization of kynurenine aminotransferase III, a novel member of a phylogenetically conserved KAT family. Yu P, Li Z, Zhang L, Tagle DA, Cai T, Gene 2006 365 111 118 10.1016/j.gene.2005.09.034 16376499
19. Mitochondrial aspartate aminotransferase: a third kynurenate-producing enzyme in the mammalian brain. Guidetti P, Amori L, Sapko MT, Okuno E, Schwarcz R, J Neurochem 2007 102 1 103 111 10.1111/j.1471-4159.2007.04556.x 17442055
20. Biochemical and structural properties of mouse kynurenine aminotransferase III. Han Q, Robinson H, Cai T, Tagle DA, Li J, Mol Cell Biol 2009 29 3 784 793 10.1128/MCB.01272-08 19029248
21. Biochemical and phenotypic abnormalities in kynurenine aminotransferase II-deficient mice. Yu P, Di Prospero NA, Sapko MT, Cai T, Chen A, Melendez-Ferro M, Du F, Whetsell WO Jr, Guidetti P, Schwarcz R, et al. Mol Cell Biol 2004 24 16 6919 6930 10.1128/MCB.24.16.6919-6930.2004 15282294
22. Purification and characterization of kynurenine aminotransferase I from human brain. Baran H, Okuno E, Kido R, Schwarcz R, J Neurochem 1994 62 2 730 738 10.1046/j.1471-4159.1994.62020730.x 8294935
23. Increased kynurenic acid levels and decreased brain kynurenine aminotransferase I in patients with Down syndrome. Baran H, Cairns N, Lubec B, Lubec G, Life Sci 1996 58 21 1891 1899 10.1016/0024-3205(96)00173-7 8637415
24. Characterization of human brain kynurenine aminotransferases using [3H]kynurenine as a substrate. Schmidt W, Guidetti P, Okuno E, Schwarcz R, Neuroscience 1993 55 1 177 184 10.1016/0306-4522(93)90464-Q 8350986
25. Substrate specificity of human glutamine transaminase K as an aminotransferase and as a cysteine S-conjugate beta-lyase. Cooper AJ, Pinto JT, Krasnikov BF, Niatsetskaya ZV, Han Q, Li J, Vauzour D, Spencer JP, Arch Biochem Biophys 2008 474 1 72 81 10.1016/j.abb.2008.02.038 18342615
26. Substrate specificity and structure of human aminoadipate aminotransferase/kynurenine aminotransferase II. Han Q, Cai T, Tagle DA, Robinson H, Li J, Biosci Rep 2008 28 4 205 215 10.1042/BSR20080085 18620547
27. Crystal structure of human kynurenine aminotransferase I. Rossi F, Han Q, Li J, Li J, Rizzi M, J Biol Chem 2004 279 48 50214 50220 10.1074/jbc.M409291200 15364907
28. Structural Insight into the Inhibition of Human Kynurenine Aminotransferase I/Glutamine Transaminase K. Han Q, Robinson H, Cai T, Tagle DA, Li J, J Med Chem 2009 52 9 2786 2793 10.1021/jm9000874 19338303
29. Crystal Structures of Glutamine:Phenylpyruvate Aminotransferase from Thermus thermophilus HB8: INDUCED FIT AND SUBSTRATE RECOGNITION. Goto M, Omi R, Miyahara I, Hosono A, Mizuguchi H, Hayashi H, Kagamiyama H, Hirotsu K, J Biol Chem 2004 279 16 16518 16525 10.1074/jbc.M311575200 14761974
30. Crystal structures of Aedes aegypti kynurenine aminotransferase. Han Q, Gao YG, Robinson H, Ding H, Wilson S, Li J, Febs J 2005 272 9 2198 2206 10.1111/j.1742-4658.2005.04643.x 15853804
31. Crystal structure of human kynurenine aminotransferase II. Han Q, Robinson H, Li J, J Biol Chem 2008 283 6 3567 3573 10.1074/jbc.M708358200 18056995
32. Crystal structure of human kynurenine aminotransferase II, a drug target for the treatment of schizophrenia. Rossi F, Garavaglia S, Montalbano V, Walsh MA, Rizzi M, J Biol Chem 2008 283 6 3559 3566 10.1074/jbc.M707925200 18056996
33. Crystal structure of a human kynurenine aminotransferase II homologue from Pyrococcus horikoshii OT3 at 2.20 A resolution. Chon H, Matsumura H, Koga Y, Takano K, Kanaya S, Proteins 2005 61 3 685 688 10.1002/prot.20614 16138312
34. Mechanism for multiple-substrates recognition of alpha-aminoadipate aminotransferase from Thermus thermophilus. Tomita T, Miyagawa T, Miyazaki T, Fushinobu S, Kuzuyama T, Nishiyama M, Proteins 2009 75 2 348 359 10.1002/prot.22245 18831049
35. Mitochondrial aspartate transaminase. II. Isolation and characterization of the multiple forms. Michuda CM, Martinez-Carrion M, Biochemistry 1969 8 3 1095 1105 10.1021/bi00831a041 4976403
36. Distinctions in the equilibrium kinetic constants of the mitochondrial and supernatant isozymes of aspartate transaminase. Michuda CM, Martinez-Carrion M, J Biol Chem 1969 244 21 5920 5927 5350945
37. Kinetic Studies of Glutamic Oxaloacetic Transaminase Isozymes. Henson CP, Cleland WW, Biochemistry 1964 3 338 345 10.1021/bi00891a007 14155095
38. Mitochondrial aspartate aminotransferase catalyses cysteine S-conjugate beta-lyase reactions. Cooper AJ, Bruschi SA, Iriarte A, Martinez-Carrion M, Biochem J 2002 368 Pt 1 253 261 10.1042/BJ20020531 12137566
39. Kynurenine aminotransferase and glutamine transaminase K of Escherichia coli: identity with aspartate aminotransferase. Han Q, Fang J, Li J, Biochem J 2001 360 Pt 3 617 623 10.1042/0264-6021:3600617 11736651
40. Endogenous kynurenines as targets for drug discovery and development. Stone TW, Darlington LG, Nat Rev Drug Discov 2002 1 8 609 620 10.1038/nrd870 12402501
41. Interpretation of the ultraviolet spectral changes of proteins. Yanari S, Bovey FA, J Biol Chem 1960 235 2818 2826 13787214
42. Mouse and human indoleamine 2,3-dioxygenase display some distinct biochemical and structural properties. Austin CJ, Astelbauer F, Kosim-Satyaputra P, Ball HJ, Willows RD, Jamie JF, Hunt NH, Amino Acids 2009 36 1 99 106 10.1007/s00726-008-0037-6 18274832
43. Indoleamine 2,3-dioxygenase. Purification and some properties. Shimizu T, Nomiyama S, Hirata F, Hayaishi O, J Biol Chem 1978 253 13 4700 4706 26687
44. Analysis of the wild-type and mutant genes encoding the enzyme kynurenine monooxygenase of the yellow fever mosquito, Aedes aegypti. Han Q, Calvo E, Marinotti O, Fang J, Rizzi M, James AA, Li J, Insect Mol Biol 2003 12 5 483 490 10.1046/j.1365-2583.2003.00433.x 12974953
45. Cloning and recombinant expression of rat and human kynureninase. Toma S, Nakamura M, Tone S, Okuno E, Kido R, Breton J, Avanzi N, Cozzi L, Speciale C, Mostardini M, et al. FEBS Lett 1997 408 1 5 10 10.1016/S0014-5793(97)00374-8 9180257
46. Purification and biochemical characterization of some of the properties of recombinant human kynureninase. Walsh HA, Botting NP, Eur J Biochem 2002 269 8 2069 2074 10.1046/j.1432-1033.2002.02854.x 11985583
47. Kynurenine pathway enzymes in different species of animals. Allegri G, Bertazzo A, Biasiolo M, Costa CV, Ragazzi E, Adv Exp Med Biol 2003 527 455 463 15206763
48. Cerebrolysin lowers kynurenic acid formation - an in vitro study. Baran H, Kepplinger B, Eur Neuropsychopharmacol 2009 19 3 161 168 10.1016/j.euroneuro.2008.09.003 19008081